Huizhen Yu - China Medicine Controller

All Insiders . USA . 
Stock . China Medicine . Stakeholders . Insider . Huizhen Yu
CHME Stock  USD 0.0002  0.00  0.00%   

Insider

Huizhen Yu is Controller of China Medicine
Age 43
Phone86 20 8739 1718
Webhttps://www.cmc621.com/cmc/index.php

China Medicine Management Efficiency

The company has return on total asset (ROA) of 0.0782 % which means that it generated a profit of $0.0782 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0663 %, meaning that it created $0.0663 on every $100 dollars invested by stockholders. China Medicine's management efficiency ratios could be used to measure how well China Medicine manages its routine affairs as well as how well it operates its assets and liabilities.
China Medicine currently holds 4.05 M in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. China Medicine has a current ratio of 10.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist China Medicine until it has trouble settling it off, either with new capital or with free cash flow. So, China Medicine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like China Medicine sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for China to invest in growth at high rates of return. When we think about China Medicine's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Deborah WeitzmanCardinal Health
59
David MyersOwens Minor
N/A
Michelle GreeneCardinal Health
53
Kevin BarryPatterson Companies
46
Jessica MayerCardinal Health
55
Tim RoganPatterson Companies
53
Tammy GomezOwens Minor
N/A
Andrea FrohningPatterson Companies
54
Graham StanleyHenry Schein
N/A
Kenneth SmithOwens Minor
40
Nicholas IIOwens Minor
53
Alex CPAOwens Minor
N/A
Stephen KlemashOwens Minor
60
Ola SnowCardinal Health
56
Kenny GardnerOwens Minor
40
Sheri EdisonCardinal Health
63
Robert HenkelOwens Minor
66
John WeilandCardinal Health
64
Aster AngagawOwens Minor
57
Dave LardyPatterson Companies
N/A
Shivani KaulPatterson Companies
N/A
China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China. CHINA MEDICINE operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 281 people. China Medicine [CHME] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Return On Equity0.0663
Return On Asset0.0782

China Medicine Leadership Team

Elected by the shareholders, the China Medicine's board of directors comprises two types of representatives: China Medicine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Medicine's management team and ensure that shareholders' interests are well served. China Medicine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Medicine's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gavin Chen, Assistant Officer
Huizhen Yu, Controller
Minhua Liu, Executive VP and Secretary
Senshan Yang, Chairman, CEO and Chairman of Guangzhou Konzern Medicine Co., Ltd
Ho Fung, Chief Officer

China Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is China Medicine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0663
Return On Asset0.0782
Profit Margin0.09 %
Operating Margin0.18 %
Current Valuation2 M
Shares Outstanding23.71 M
Price To Earning(6.67) X
Price To Book0.07 X
Price To Sales0.01 X
Revenue64.75 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
TITANTitan Company Limited
UUnity Software
PAYCPaycom Soft

Other Information on Investing in China Pink Sheet

China Medicine financial ratios help investors to determine whether China Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in China with respect to the benefits of owning China Medicine security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY